• Scheduled Maintenance to your CardioMEMS HF System

    From Friday, November 13, 2026, at 5:00 PM PDT through Sunday, November 15, 2026, at 5 PM PDT your CardioMEMS patient reader (CardioMEMS Patient Electronics System or CardioMEMS HERO Device) may be unable to send readings to your care team. Please continue taking your readings as instructed. Any readings taken during this time will be saved on your device and should automatically be sent once service is restored. You do not need to take any additional action. If you have questions or experience issues after service is restored, please contact Abbott HF Technical Support at 844-692-6367 (Mon-Fri, 8 a.m.-8 p.m. EDT). Thank you for your patience as we complete these updates.

    MAT-2682341 v1.0

Live More
Worry Less

Pulmonary artery pressure monitoring

Live More Worry Less

Important Safety Information

By Prescription Only

Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

CardioMEMS™ HF System Indications and Usage: The CardioMEMS HF System is indicated for wirelessly measuring and monitoring pulmonary artery pressure and heart rate in NYHA Class II or III heart failure patients who either have been hospitalized for heart failure in the previous year and/or have elevated natriuretic peptides. The hemodynamic data are used by physicians for heart failure management with the goal of controlling pulmonary artery pressures and reducing heart failure hospitalizations.

Contraindications: The CardioMEMS™ HF System is contraindicated for patients with an inability to take dual antiplatelet or anticoagulants for one month post implant.

CardioMEMS™ HF System Potential Adverse Events:  Potential adverse events associated with the implantation procedure include, but are not limited to, the following: air embolism, allergic reaction, infection, delayed wound healing, arrhythmias, bleeding, hemoptysis, hematoma, nausea, cerebrovascular accident, thrombus, cardiovascular injury, myocardial infarction, death, embolization, thermal burn, cardiac perforation, pneumothorax, thoracic duct injury and hemothorax.

MAT-2100757 v5.0